Digital Health

Mastering digital health solutions

We combine medicines with digital health technologies to create patient-focused solutions for better therapies worldwide.

Pharmaceuticals of the Future

Better therapies by combining medicines with digital health

At Tiefenbacher Group, we combine proven pharmaceuticals with cutting-edge digital health solutions to create next-generation therapies. Our mission is to make healthcare smarter, more personalized, and more effective — empowering patients and improving lives worldwide.

As a pioneer in digital health we have launched together with our partner Ondosis the innovative healthcare brand OYSTA. With OYSTA we want to revolutionize the way how patients take their medicines so that every individual precisely gets the right dose they need in a simpler and more comfortable way. By combining pharmaceuticals with digital health technology we aim for an intuitive, precise, and flexible dosing of life improving medicines.

 

Tiefenbacher Group - A pale blue hexagon with soft edges, centered on a white background, represents the streamlined approach of generic medicines manufacturing.

Facts & figures

Smart Solutions, Real Impact

TIEFENBACHER MEDICAL DEVICES develops drug-device combination products that improve patient outcomes while navigating complex regulatory challenges. We manage every stage—from initial concept to manufacture and lifecycle management—delivering smart, user-friendly solutions that meet the needs of patients, physicians, and the broader healthcare ecosystem.

we’re here for your questions and ideas

Get in Touch

Launch of Tiefenbacher Group and Ondodis

The innovative healthcare solution OYSTA

In 2022, Tiefenbacher Group and Ondosis launched the healthcare brand OYSTA®, aiming to revolutionize medication intake with precise, comfortable, and intuitive dosing through a connected handheld device and digital follow-up. OYSTA® supports patients with conditions like ADHD, rare pulmonary diseases, and transplantation medicine by enabling individualized dosing, safe medication management, and treatment monitoring. The solution combines two synergistic tools: the OYSTA® Dosage Manager (digital dispensing device with medicine) and OYSTA® Digital Service, offering a comprehensive approach for patients, caregivers, and healthcare providers. Visit oysta-health.com to learn more.
*Dosage Manager and Digital Service are in development and not yet FDA-approved.

You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Future innovations

Dedication to innovation, technology, and continuous improvement

We turn drug-delivery device concepts into market-ready medical devices with optional eHealth applications, quickly and cost-efficiently. From concept to commercial manufacturing, we manage regulatory compliance, supply chains, and device validation. For marketed products, we cover all lifecycle activities, including vigilance, post-market follow-up, risk management, and quality audits. Our smart solutions simplify processes, save time and cost, and continuously improve treatment outcomes.

Tiefenbacher Group - A diagram showing the integration of product engineering, device lifecycle management, generic medicines manufacturing, and quality management. A circular process highlights quality audits, vigilance, updates, evaluation, risk management, and surveillance.